P0314: External validation of ultrasound scores for Crohn's Disease: IBUS-SAS, BUSS, SUS-CD, Simple-USECCO'25Year: 2025
Authors: Melotti, L.(1)*;Dussias, N.(2);Mazzotta, E.(1);Calabrese, C.(2);Scaioli, E.(1);Gionchetti, P.(2);Rizzello, F.(2);
(1)IRCCS Azienda Ospedaliero Universitaria di Bologna- Policlinico Sant'Orsola-Malpighi, Dept of Medical and Surgical Sciences, Bologna, Italy;(2)University of Bologna, Dept of Medical and Surgical Sciences, Bologna, Italy;
1) G. Dragoni et al., «Correlation of Ultrasound Scores with Endoscopic Activity in Crohn’sDisease: A Prospective Exploratory Study», J Crohns Colitis, vol. 17, n. 9, pagg. 1387–1394, ott. 2023, doi: 10.1093/ecco-jcc/jjad068.
P0315: Incidence and risk factors for disease progression in patients with ulcerative proctitis: a retrospective cohort studyECCO'25Year: 2025
Authors: Pierik, R.J.(1)*;Derikx, L.A.A.P.(1);Hoekstra, J.(2);Post, R.A.J.(3);van Dongen, R.E.A.(2);de Vries, A.C.(1);Bodelier, A.G.L.(2);
(1)Erasmus Medical Center, Gastroenterology and Hepatology, Rotterdam, The Netherlands;(2)Amphia Hospital, Gastroenterology and Hepatology, Breda, The Netherlands;(3)Erasmus Medical Center, Biostatistics, Rotterdam, The Netherlands;
1. Meucci G, Vecchi M, Astegiano M, et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol. 2000;95(2):469-473.
2. Huguet JM, Ferrer-Barceló L, Suárez P, et al. Endoscopic progression of ulcerative proctitis to proximal disease. Can we identify predictors of progression?. Scand J Gastroenterol. 2018;53(10-11):1286-1290.
3. Walsh E, Chah YW, Chin SM, et al. Clinical Predictors and Natural History of Disease Extension in Patients with Ulcerative Proctitis. Inflamm Bowel Dis. 2017;23(11):2035-2041.
4. Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012;41(3):861-870.
P0316: Systematic assessment of primary sclerosing cholangitis using magnetic resonance cholangiopancreatography in newly diagnosed inflammatory bowel disease – a prospective population-based inception cohort studyECCO'25Year: 2025
Authors: Attauabi, M.(1,2)*;Roager Madsen, G.(2,3);Møller, J.(4);Nielsen, Y.J.W.(4);Bøjer Jensen, A.(5);Krieger Jensen, F.(5);Siebner, H.R.(6,7,8);Fallentin, E.(9);Bendtsen, F.(2,3,10);Seidelin, J.B.(10,11);Burisch, J.(10,12,13);
(1)Copenhagen University Hospital - Herlev and Gentofte- Herlev, Department of Gastroenterology and Hepatology, Herlev, Denmark;(2)Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents- and Adults, Hvidovre, Denmark;(3)Copenhagen University Hospital - Amager and Hvidovre- Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;(4)Copenhagen University Hospital - Herlev and Gentofte- Herlev, Department of Radiology, Herlev, Denmark;(5)Centre for Functional and Diagnostic Imaging and Research- Copenhagen University Hospital - Amager and Hvidovre- Hvidovre, Department of Radiology, Hvidovre, Denmark;(6)Copenhagen University Hospital - Amager and Hvidovre- Hvidovre, Danish Research Centre for Magnetic Resonance- Centre for Functional and Diagnostic Imaging and Research, Hvidovre, Denmark;(7)Copenhagen University Hospital - Bispebjerg and Frederiksberg-, Department of Neurology, Copenhagen, Denmark;(8)Faculty of Health and Medical Sciences- University of Copenhagen-, Department of Clinical Medicine, Copenhagen, Denmark;(9)Copenhagen University Hospital - Rigshospitalet, Department of Radiology, Copenhagen, Denmark;(10)Faculty of Health and Medical Sciences- University of Copenhagen, Department of Clinical Medicine, Copenhagen, Denmark;(11)Rigshospitalet, Dept. of Digestive Diseases- Transplantation and General Surgery- IBD Section, Copenhagen, Denmark;(12)Copenhagen University Hospital - Amager and Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;(13)Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents- and Adults-, Hvidovre, Denmark;
1. Attauabi M, Madsen GR, Bendtsen F, et al. Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study. BMJ Open. 2022;12(6):e055779. doi:10.1136/bmjopen-2021-055779
P0317: Risk factors of Post Operative Recurrence in patients with Crohn’s Disease: a multicentre experience of 8 years of follow-upECCO'25Year: 2025
Authors: Cannatelli, R.(1)*;Ferretti, F.(1);Ding, N.S.(2);Lai, M.(2);Carvalhas Gabrielli, A.M.(1);Monaca, F.(3);Carmagnola, S.(1);Colombo, F.(4);Maconi, G.(3);
(1)ASST Fatebenefratelli Sacco, Gastroenterology Unit, Milan, Italy;(2)St Vincent’s Hospital, Department of Gastroenterology, Melbourne, Australia;(3)University of Milan, Department of Biomedical and Clinical Sciences, Milan, Italy;(4)ASST Fatebenefratelli Sacco, Division of General Surgery “Luigi Sacco”, Milan, Italy;
1. Bak MTJ, Demers K, Hammoudi N, et al. Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's disease. Aliment Pharmacol Ther. 2024;60(3):310-326. doi: 10.1111/apt.18040.
2. Tsai L, Ma C, Dulai PS, et al. Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts. Clin Gastroenterol Hepatol. 2021;19(10):2031-2045.e11. doi: 10.1016/j.cgh.2020.10.039.
P0318: Rapid access clinics for Inflammatory Bowel Disease improve access and outcomes but additional service support is required: Experience from the AWARE-IBD Quality Improvement Programme in the United KingdomECCO'25Year: 2025
Authors: Mccormick, S.(1)*;Robinson, K.(1);Ezaydi, N.(2);Ainley, R.(3);Lobo, A.J.(1);
(1)Sheffield Teaching Hospitals NHS Foundation Trust, Gastroenterology, Sheffield, United Kingdom;(2)The University of Sheffield, Sheffield Centre for Health and Related Research, Sheffield, United Kingdom;(3)Crohn's & Colitis UK, Research and Evidence, Hatfield, United Kingdom; Sheffield AWARE-IBD (R. Ainley, J. Armitage, A.J. Brooks, R. Campbell, T.S. Chew, N. Ezaydi, M. Hale, D. Hind, A.J. Lobo, S.J. McCormick, L. Marshall, M. Nalishuwa, A.M. Phillips, A. Rej, K. Robinson, E. Sheldon, G.Z. Tun, L. Thompson, J. Turner, A. Wright)
P0321: Early improvement of mental health is associated with long-term disease remission in Ulcerative ColitisECCO'25Year: 2025
Authors: Zheng, J.(1)*;Huang, P.(2);Feng, R.(3);Li, L.L.(1);Chen, M.(1);Chen, R.(1);Zhang, S.(1);
(1)The First Affiliated Hospital- Sun Yat-sen University, Department of Gastroenterology, Guangzhou, China;(2)Sun Yat-sen University, Zhongshan School of Medicine, Guangzhou, China;(3)University of Manchester, University of Manchester, Manchester, United Kingdom;
P0322: Global coagulation assays for the assessment of hypercoagulable states in Inflammatory Bowel Diseases.ECCO'25Year: 2025
Authors: Rueda Garcia, J.L.(1,2)*;Monzón Manzano, E.(2,3);Acuña, P.(2,3);Martín - Arranz, E.(1,2);Suárez Ferrer, C.(1,2);Poza Cordón, J.(1,2);Sánchez - Azofra, M.(1,2);García Ramírez, L.(2);Arias-Salgado , E.G.(2,3);García - Rojas, C.(2);Noci, J.(1);Cubillo García, C.(2);Butta, N.(2,3);Martín - Arranz, M.D.(1,2,4);
(1)La Paz University Hospital, Gastroenterology, Madrid, Spain;(2)La Paz University Hospital, La Paz Institute for Health Research idiPAZ, Madrid, Spain;(3)La Paz University Hospital, Hematology and Hemotherapy, Madrid, Spain;(4)Universidad Autónoma de Madrid, Facultad de Medicina, Madrid, Spain; IdiPAZ Study Group for Immune-Mediated Gastrointestinal Diseases.
1. Gordon H, Burisch J, Ellul P, Karmiris K, Katsanos K, Allocca M, et al. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. J Crohn’s Colitis. 2023 Jun 23;1–76.
2. Hartmann J, Hermelin D, Levy JH. Viscoelastic testing: an illustrated review of technology and clinical applications. Res Pract Thromb Haemost [Internet]. 2023;7(1):100031
P0323: Serum leucine-rich α2-glycoprotein (LRG) and Monocyte chemoattractant protein-1 (MCP-1) as Novel Biomarkers for Predicting Vedolizumab Response in Ulcerative Colitis PatientsECCO'25Year: 2025
Authors: Yoshihara, T.(1)*;Shinzaki, S.(2);Naka, T.(3);Iijima, H.(4);Hayashi, Y.(1);Inoue , T.(1);Tsujii, Y.(1);Uema , R.(1);Otake-Kasamoto, Y.(1);Tani, M.(1);Amano, T.(1);Tashiro, T.(1);Asakura, A.(1);Sakakibara, Y.(5);Yamada, T.(6);Hiyama, S.(7);Nishida , T.(8);Ishiguro, K.(9);Baba, Y.(9);Takehara , T.(1);
(1)Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Osaka, Japan;(2)Hyogo Medical University School of Medicine, Department of Gastroenterology, Hyogo, Japan;(3)School of Medicine Iwate Medical University, Division of Allergy and Rheumatology- Department of Internal Medicine & Institute for Biomedical Sciences Molecular Pathophysiology, Yahaba, Japan;(4)Osaka Keisatsu Hospital, International Medical & Science Center, Osaka, Japan;(5)National Hospital Organization Osaka National Hospital, Department of Gastroenterology and Hepatology, Osaka, Japan;(6)Osaka Rosai Hospital, Department of Gastroenterology and Hepatology, Osaka, Japan;(7)Japan Community Health Care Organization Osaka Hospital, Department of Gastroenterology and Hepatology, Osaka, Japan;(8)Toyonaka Municipal Hospital, Department of Gastroenterology, Osaka, Japan;(9)Takeda Pharmaceutical Company Limited, Japan Medical Office, Tokyo, Japan;
P0324: Lower Bone Mineral Density and alterations in bone biomarkers DKK-1, Sclerostin, and Periostin in individuals with Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Palatianou, M.(1)*;Tsentidis, C.(2);Tzouvala, M.(3);Papaconstantinou, I.(4);Vezakis, A.(4);Gourgiotis, D.(5);Marmarinos, A.(5);Karamanolis5, G.(6);
(1)"Agios Panteleimon" General Hospital of Nikaia-Piraeus- "Agia Varvara" General Hospital of Western Attica- Nikaia, Department of Gastroenterology, Piraeus, Greece;(2)"Agios Panteleimon"General Hospital of Nikaia-Piraeus- Piraeus, Department of Endocrinology- Metabolism & Diabetes Mellitus, Piraeus, Greece;(3)"Agios Panteleimon" General Hospital of Nikaia-Piraeus- "Agia Varvara" General Hospital of Western Attica- Nikaia- Piraeus, Department of Gastroenterology, Piraeus, Greece;(4)National and Kapodistrian University of Athens, Department of Surgery- Aretaieion University Hospital, Athens, Greece;(5)National and Kapodistrian University of Athens, Laboratory of Clinical Biochemistry-Molecular Diagnostic, Athens, Greece;(6)National and Kapodistrian University of Athens, Gastroenterology Unit- Second Department of Surgery- Aretaieion University Hospital- School of Medicine, Athens, Greece;
1. Du B, Luo S, Zhu X, et al. WAY-262611 ameliorates the inflammatory bowel disease by activating Wnt/β-catenin pathway. In Vitro Cell Dev Biol Anim. 2024;60(2):128-138.
2. Palatianou ME, Karamanolis G, Tsentidis C, et al. Signaling pathways associated with bone loss in inflammatory bowel disease. Ann Gastroenterol. 2023;36(2):132-140.
3. Keskin M, Topkaç A. The predictive value of periostin to diagnose Crohn's disease. Turk J Gastroenterol. 2022;33(2):127-135.
4. Kim MJ, Choe YH. Correlation of Dickkopf-1 with inflammation in Crohn disease. Indian Pediatr. 2019;56(11):929-932.
This study was supported by a research grant (2020EOMIFNEp6) from the Hellenic Group for the Study of Inflammatory Bowel Disease (EOMIFNE)
P0326: Environmental factors, genetic predisposition and subclinical inflammation in the development of perinuclear-antineutrophil cytoplasmic antibody (P-ANCA)-positive ulcerative colitis: A European twin studyECCO'25Year: 2025
Authors: Bergemalm, D.(1)*;Amcoff, K.(1);Pierik, M.J.(2);Colombel, J.F.(3);Vermeire, S.(4);Bodin, L.(5);Halfvarson, J.(1);
(1)Faculty of Medicine and Health- Örebro University, Department of Gastroenterology, Örebro, Sweden;(2)University Hospital Maastricht, Gastroenterology, Maastricht, The Netherlands;(3)Icahn School of Medicine at Mount Sinai, Division of Gastroenterology-, New York, United States;(4)University Hospital Gasthuisberg, Department of Gastroenterology, Leuven, Belgium;(5)Institute of Environmental Medicine- Karolinska Institutet, Unit of Intervention and Implementation Research, Stockholm, Sweden;
P0327: Histologic remission predicts endoscopic remission in patients with ulcerative colitisECCO'25Year: 2025
Authors: Aouroud, H.(1)*;Lairani, F.E.(1);Aouroud, M.(1);Nacir, O.(1);Ait Errami, A.(1);Oubaha, S.(1);Samlani, Z.(1);Krati, K.(1);
(1)Mohammed VI university Hospital, Gastro-enterology, Marrakech, Morocco;
P0328: Faecal calprotectin and MRI are complementary tools for assessing treatment efficacy and predicting the risk of bowel damage progression in Crohn's disease: results of the IZNOGOUD studyECCO'25Year: 2025
Authors: Buisson, A.(1)*;Guilmoteau, T.(1);Allimant, C.(2);Pereira, B.(1);
(1)CHU Clermont-Ferrand, IBD Unit, Clermont-Ferrand, France;(2)CH Métropole Savoie, IBD Unit, Chambéry, France;
P0329: Clostridium difficile infection associates with the need for biologics: a retrospective long-term analysis in a cohort of 102 ibd patients.ECCO'25Year: 2025
Authors: Spagnuolo, R.(1)*;Scarlata, G.G.M.(1);Morano, D.(1);Imoletti, F.(1);Suraci, E.(2);Marasco, R.(2);Imeneo, M.G.(2);Pavia, G.(3);Pantanella, M.(3);Calabretta, M.V.(3);Marascio, N.(3);Quirino, A.(3);Trecarichi, E.M.(4);Russo , A.(4);Abenavoli, L.(1);Matera, G.(3);Luzza, F.(1);
(1)Magna Graecia University, Health Sciences, Catanzaro, Italy;(2)University General Hospital "R. Dulbecco", IBD Unit, Catanzaro, Italy;(3)Magna Graecia University, Unit of Clinical Microbiology- Department of Health Sciences, Catanzaro, Italy;(4)Magna Graecia University, Infectious and Tropical Disease Unit- Department of Medical and Surgical Sciences, Catanzaro, Italy;
P0330: The diagnostic pathway of paediatric Inflammatory Bowel Disease in a Scottish regional centre before, during and after the Covid Pandemic: Good access to endoscopy but MRI lagging behindECCO'25Year: 2025
Authors: Motion, J.(1)*;Kishore, S.(1);Hansen, R.(2);Stewart, C.(1);Watson, R.(1);Lang, S.(3);Chalmers, I.(1);
(1)Royal Aberdeen Children's Hospital, Paediatric Gastroenterology, Aberdeen, United Kingdom;(2)University of Dundee, School of Medicine, Dundee, United Kingdom;(3)Robert Gordon's University, School of Health, Aberdeen, United Kingdom;
1.IBD UK. IBD Standards [Internet]. IBD UK. 2019. Available from: https://ibduk.org/ibd-standards, Accessed 11/11/24
P0331: Insights from the Polish Registry of Microscopic Colitis. The Overlapping Symptoms of Microscopic Colitis and Irritable Bowel Syndrome.ECCO'25Year: 2025
Authors: Bielski , A.(1)*;Marlicz , W.(2);Małecka-Wojciesko , E.(3);Reguła , J.(4);Mróz , A.(5);Zwolińska-Wcisło , M.(6);Waśko-Czopnik , D.(7);Eder , P.(8);Daniluk , J.(9);Rosołowski , M.(10);Rydzewska , G.(1);
(1)National Medical Institute of the Ministry of the Interior and Administration, Department of Gastroenetrology and Internal Medicine, Warsaw, Poland;(2)Pomeranian Medical University, Department of Gastroenterology, Szczecin, Poland;(3)Medical University of Lodz, Department of Digestive Tract Diseases, Lodz, Poland;(4)Maria Sklodowska-Curie National Research Institute of Oncology, Department of Oncological Gastroenterology, Warsaw, Poland;(5)Maria Sklodowska-Curie National Research Institute of Oncology, Department of Pathology, Warsaw, Poland;(6)Jagiellonian University Medical College, Department of Gastroenterology and Hepatology, Krakow, Poland;(7)Medical University of Wroclaw, Department of Gastroenterology and Hepatology, Wroclaw, Poland;(8)Poznan University of Medical Sciences- Heliodor Swiecicki University Hospital, Department of Gastroenterology, Dietetics and Internal Medicine, Poznan, Poland;(9)Medical University of Bialystok, Department of Gastroenterology and Internal Medicine, Bialystok, Poland;(10)Medical University of Bialystok, Department of Internal Medicine and Hypertension, Bialystok, Poland;
P0332: Optimization and assessment of colonoscopy preparation in Inflammatory Bowel Disease: a comprehensive single-center analysis with focus on disease-specific factorsECCO'25Year: 2025
Authors: Saidani, R.(1)*;Cherif, D.(1);Hassine, H.(1);Yacoub, H.(1);Debbabi, H.(1);Kchir, H.(1);Maamouri, N.(1);
(1)University hospital of La Rabta, Gastroenterology B, Tunis, Tunisia;
P0333: Predictive factors for thiopurine treatment failure in anti-TNF naïve IBD patients: Insights from a tertiary care Hepato-Gastroenterology center experienceECCO'25Year: 2025
Authors: Adamou Mainassra, F.(1)*;Hassini, A.(2);Essadi , B.(2);Koulali, H.(2);Elmqaddem, O.(2);Zazour, A.(2);Zahi, I.(2);Kharrasse, G.(2);
(1)Hepato-Gastroenterology Service- Mohammed VI University Hospital Center CHU- Oujda- Mohammed First University- Oujda- Research Laboratory for Digestive System Diseases LARMAD- Morocco, Departement, Department of Hepato-Gastroenterology, Morocco;(2)Hepato-Gastroenterology Service- Mohammed VI University Hospital Center Oujda, Department of Hepato-Gastroenterology, oujda, Morocco;
